Corteva, Inc.
CTVALast close · Oct 16, 202612.88+0.00 (+0.00%)
Market cap$8.6B
9 firms' latest targets, last 90 days: median $17.00 ($15.00–$101.00), 32% above the last close.
Price and published targets
Each firm's latest target
| Date | Firm | Target | Change | Vs price now |
|---|---|---|---|---|
| 2026-10-12 | UBS | $15.00 | ▼ 83% | +16% |
| 2026-10-08 | Goldman Sachs | $20.00 | ▼ 77% | +55% |
| 2026-10-07 | RBC Capital | $17.00 | ▼ 83% | +32% |
| 2026-10-07 | KeyBanc | $17.00 | — | +32% |
| 2026-10-05 | New Street | $17.00 | ▼ 82% | +32% |
| 2026-10-05 | Oppenheimer | $17.00 | ▼ 82% | +32% |
| 2026-10-02 | BMO Capital | $15.00 | ▼ 84% | +16% |
| 2026-10-02 | Morgan Stanley | $18.00 | ▼ 81% | +40% |
| 2026-08-03 | Deutsche Bank | $101.00 | — | +684% |
Consensus estimates
| FY | Revenue | YoY | EPS | YoY | Revenue range | EPS range | Analysts |
|---|---|---|---|---|---|---|---|
| 2022reported | $17.5B | +11% | $1.58 | -33% | est. $17.4B+0% | est. $2.57 | 6 |
| 2023reported | $17.2B | -1% | $1.03 | -35% | est. $17.1B+1% | est. $2.60 | 15 |
| 2024reported | $16.9B | -2% | $1.30 | +26% | est. $16.9B+0% | est. $0.38 | 11 |
| 2025reported | $17.4B | +3% | $1.60 | +23% | est. $17.7B-2% | est. $0.50 | 13 |
| 2026 | $17.5B | +1% | $0.57 | +14% | $17.4B–$17.6B | $0.36–$1.08 | 7 |
| 2027 | $8.1B | -54% | $0.73 | +27% | $8.0B–$8.1B | $0.56–$0.94 | 8 |
| 2028 | $8.3B | +3% | $0.84 | +16% | $7.8B–$11.0B | $0.68–$0.96 | 9 |
| 2029 | $8.6B | +3% | $0.77 | -8% | $8.2B–$10.4B | $0.74–$0.99 | 4 |
Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.